Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Amphion Innovations partner Kromek buys California-based NOVA R&D to add 22 patents

Amphion Innovations partner Kromek buys California-based NOVA R&D to add 22 patents

IP commercialisation company Amphion Innovations (LON:AMP) said its partner company Kromek has completed the acquisition of California-based NOVA R&D Inc to add 22 patents in imaging and radiation detection to its portfolio.

Amphion said that NOVA had a number of important technologies and products in the chemical, biological, radiological, and nuclear (CBRNE) space and significant commercial relationships in these vital and growing markets.

The deal is expected to strengthen Kromek’s position in the imaging and detection market and improve its capabilities in the field of electronics and application-specific integrated circuit (ASIC) design as well as provide it with a permanent presence in the UK.

Kromek’s directors are now expecting the acquisition to give the company more freedom to integrate and develop core technologies, helping it confirm its position as “one of the few companies in the world with such technical capabilities and scope".

“The acquisition of NOVA is a major milestone for Kromek, bringing with it an important IP portfolio, relationships, technologies and products.  I look forward to further exciting developments as Kromek continues to develop and implement its innovative technologies,” said chief executive of Amphion and chairman of Kromek Richard C.E. Morgan.

UK based Kromek specialises in the development of disruptive technology products for a range of commercial markets. The company is pioneering the digital colour imaging of x-rays and advanced 3D imaging for the medical, security, industrial inspection and defence markets.

Amphion currently has eight partner companies developing proven technologies targeting substantial commercial marketplaces in excess of US$1 billion.  Each partner company aims to achieve a target exit value in excess of US$100 million.

The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the partner companies.  The partner companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

Shares in Amphion were up nearly 4% by midday in an otherwise depressed market.

View full AMP profile View Profile

Amphion Innovations Plc Timeline

Related Articles

Passengers at an airport
September 25 2017
Things always take time in Westminster's line of work, but the group is edging closer to a Middle East contract that should transform the group
1505724201_learningtechnology.jpg
September 18 2017
Broker Numis thinks the benefits of the NetDimensions deal will be felt in the fourth quarter
Jobs market
September 19 2017
A flexible jobs market, an increase in short-term contracts - all play to the strengths of the specialist in background checks

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use